In some hematological malignancies, RUNX1 proteins have been found to fuse with other genes, such as RUNX1-ETO fusion in 10–20% of AML patients and TEL-RUNX1 fusion in 20–25% of childhood ALL patients [65,99]. Here, RUNX1 is linked to acute lymphoblastic leukemia.